Takeda And Pfizer Sign A Co-Promotion Deal To Market Actos In China
This article was originally published in The Pink Sheet Daily
Executive Summary
With an exclusive deal for a fading blockbuster in diabetes, Takeda makes good on a pledge to get serious about emerging markets.